These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34208)

  • 21. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Cuesta MJ; García de Jalón E; Campos MS; Moreno-Izco L; Lorente-Omeñaca R; Sánchez-Torres AM; Peralta V
    Schizophr Res; 2018 Oct; 200():97-103. PubMed ID: 28890132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neuroleptics.
    Singh MM; Kay SR
    Neuropsychobiology; 1978; 4(5):288-304. PubMed ID: 673165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender.
    Torgalsbøen AK
    Psychiatry Res; 1999 Nov; 88(2):143-52. PubMed ID: 10622350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Catamnestic studies of treatment results in schizophrenic patients].
    Saarma J
    Psychiatr Neurol Med Psychol (Leipz); 1983 Oct; 35(10):587-97. PubMed ID: 6140696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social influences on the prognosis of schizophrenia.
    Beck JC
    Schizophr Bull; 1978; 4(1):86-101. PubMed ID: 34211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Descriptive approach to latent forms of schizophrenia].
    Rivet B; Bougerol T; Cura B; Llorca PM; Lançon C; Scotto JC
    Encephale; 1994; 20(1):17-25. PubMed ID: 8174507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses].
    Möller HJ; Scharl W; von Zerssen D
    Nervenarzt; 1984 Jul; 55(7):358-64. PubMed ID: 6472525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postural and reflex integration in schizophrenic patients.
    Endler PB; Eimon MC
    Am J Occup Ther; 1978 Aug; 32(7):456-9. PubMed ID: 696545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on premorbid personality development in schizophrenia].
    Bräutigam W
    Nervenarzt; 1974 Jun; 45(6):298-304. PubMed ID: 4849788
    [No Abstract]   [Full Text] [Related]  

  • 31. Subtype stability in schizophrenia.
    Kendler KS; Gruenberg AM; Tsuang MT
    Am J Psychiatry; 1985 Jul; 142(7):827-32. PubMed ID: 4014504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of schizophrenia in character disordered patients.
    Fenton WS; McGlashan TH
    Am J Psychiatry; 1989 Oct; 146(10):1280-4. PubMed ID: 2782471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further data concerning the relation between premorbid adjustment and paranoid symptomatology.
    Goldstein MJ
    Schizophr Bull; 1978; 4(2):236-43. PubMed ID: 746374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homicidal aggression in schizophrenic men.
    Planansky K; Johnston R
    Acta Psychiatr Scand; 1977 Jan; 55(1):65-73. PubMed ID: 842384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The place of insulin coma therapy among the current methods of treating patients with paroxysmal schizophrenia].
    Kalinin VV; Rudik VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(5):745-9. PubMed ID: 3739489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early diagnosis, variety of outcomes and prognosis of juvenile schizophrenia with over-value disorders of the "metaphysical intoxication" type onset (results of a late follow-up study)].
    Tsutsul'kovskaia MIa; Izvol'skiĭ SA; Bol'zho AG; Kopeĭko GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):73-81. PubMed ID: 3953198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
    Möller HJ; von Zerssen D
    Nervenarzt; 1985 Sep; 56(9):498-505. PubMed ID: 2867479
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early stages of schizophrenia, challenges and prospects].
    Le Galudec M; Stephan F; Mascret R; Hazif-Thomas C; Walter M
    Soins Psychiatr; 2011; (274):35-8. PubMed ID: 21591380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.